These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 36435063)

  • 1. Mucosal-associated invariant T cells reduce and display tissue-resident phenotype with elevated IL-17 producing capacity in non-small cell lung cancer.
    Ouyang L; Wu M; Zhao J; Jiang L; Shen Z; Cheng X; Wang W; Wu X; Cao X; Weng X
    Int Immunopharmacol; 2022 Dec; 113(Pt B):109461. PubMed ID: 36435063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCR6-positive circulating mucosal-associated invariant T cells can identify patients with non-small cell lung cancer responding to anti-PD-1 immunotherapy.
    Qu J; Wu B; Chen L; Wen Z; Fang L; Zheng J; Shen Q; Heng J; Zhou J; Zhou J
    J Exp Clin Cancer Res; 2024 May; 43(1):134. PubMed ID: 38698468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and predictive value of MAIT cells in non-small cell lung cancer for immunotherapy.
    Shi L; Lu J; Zhong D; Song M; Liu J; You W; Li WH; Lin L; Shi D; Chen Y
    J Immunother Cancer; 2023 Jan; 11(1):. PubMed ID: 36657812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Blood Mucosal-Associated Invariant T Cells in Patients With Axial Spondyloarthritis and of Resident Mucosal-Associated Invariant T Cells From the Axial Entheses of Non-Axial Spondyloarthritis Control Patients.
    Rosine N; Rowe H; Koturan S; Yahia-Cherbal H; Leloup C; Watad A; Berenbaum F; Sellam J; Dougados M; Aimanianda V; Cuthbert R; Bridgewood C; Newton D; Bianchi E; Rogge L; McGonagle D; Miceli-Richard C
    Arthritis Rheumatol; 2022 Nov; 74(11):1786-1795. PubMed ID: 35166073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MAIT cells are associated with responsiveness to neoadjuvant immunotherapy in COPD-associated NSCLC.
    Yin Y; Zeng A; Abuduwayiti A; Xu Z; Chen K; Wang C; Fang X; Wang J; Jiang G; Dai J
    Cancer Med; 2024 Mar; 13(6):e7112. PubMed ID: 38509769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune checkpoint blockade improves the activation and function of circulating mucosal-associated invariant T (MAIT) cells in patients with non-small cell lung cancer.
    Sundström P; Dutta N; Rodin W; Hallqvist A; Raghavan S; Quiding Järbrink M
    Oncoimmunology; 2024; 13(1):2312631. PubMed ID: 38343750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation and Functional Alteration of Mucosal-Associated Invariant T Cells in Adult Patients With Community-Acquired Pneumonia.
    Ouyang L; Wu M; Shen Z; Cheng X; Wang W; Jiang L; Zhao J; Gong Y; Liang Z; Weng X; Yu M; Wu X
    Front Immunol; 2021; 12():788406. PubMed ID: 34992604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging Public Single-Cell and Bulk Transcriptomic Datasets to Delineate MAIT Cell Roles and Phenotypic Characteristics in Human Malignancies.
    Yao T; Shooshtari P; Haeryfar SMM
    Front Immunol; 2020; 11():1691. PubMed ID: 32849590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating and tumor-infiltrating mucosal associated invariant T (MAIT) cells in colorectal cancer patients.
    Ling L; Lin Y; Zheng W; Hong S; Tang X; Zhao P; Li M; Ni J; Li C; Wang L; Jiang Y
    Sci Rep; 2016 Feb; 6():20358. PubMed ID: 26837580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucosal-Associated Invariant T Cells Display Diminished Effector Capacity in Oesophageal Adenocarcinoma.
    Melo AM; O'Brien AM; Phelan JJ; Kennedy SA; Wood NAW; Veerapen N; Besra GS; Clarke NE; Foley EK; Ravi A; MacCarthy F; O'Toole D; Ravi N; Reynolds JV; Conroy MJ; Hogan AE; O'Sullivan J; Dunne MR
    Front Immunol; 2019; 10():1580. PubMed ID: 31354725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of circulating mucosal-associated invariant T cell levels and their anti-cancer activity in patients with mucosal-associated cancer.
    Won EJ; Ju JK; Cho YN; Jin HM; Park KJ; Kim TJ; Kwon YS; Kee HJ; Kim JC; Kee SJ; Park YW
    Oncotarget; 2016 Nov; 7(46):76274-76290. PubMed ID: 27517754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-17A-producing sinonasal MAIT cells in patients with chronic rhinosinusitis with nasal polyps.
    Rha MS; Yoon YH; Koh JY; Jung JH; Lee HS; Park SK; Park SH; Kim YM; Rha KS; Shin EC
    J Allergy Clin Immunol; 2022 Feb; 149(2):599-609.e7. PubMed ID: 34403659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and increased production of interleukin-17 and tumour necrosis factor-α of mucosal-associated invariant T cells in patients with periodontitis.
    Kim OS; Park KJ; Jin HM; Cho YN; Kim YS; Kwon SH; Koh JT; Ju JK; Kee SJ; Park YW
    J Clin Periodontol; 2022 Jul; 49(7):706-716. PubMed ID: 35569027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal associated invariant T cells from human breast ducts mediate a Th17-skewed response to bacterially exposed breast carcinoma cells.
    Zumwalde NA; Haag JD; Gould MN; Gumperz JE
    Breast Cancer Res; 2018 Sep; 20(1):111. PubMed ID: 30208917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exhaustion in tumor-infiltrating Mucosal-Associated Invariant T (MAIT) cells from colon cancer patients.
    Rodin W; Sundström P; Ahlmanner F; Szeponik L; Zajt KK; Wettergren Y; Bexe Lindskog E; Quiding Järbrink M
    Cancer Immunol Immunother; 2021 Dec; 70(12):3461-3475. PubMed ID: 33885944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-17 producing mucosal associated invariant T cells - emerging players in chronic inflammatory diseases?
    Pisarska MM; Dunne MR; O'Shea D; Hogan AE
    Eur J Immunol; 2020 Aug; 50(8):1098-1108. PubMed ID: 32617963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-7 primes IL-17 in mucosal-associated invariant T (MAIT) cells, which contribute to the Th17-axis in ankylosing spondylitis.
    Gracey E; Qaiyum Z; Almaghlouth I; Lawson D; Karki S; Avvaru N; Zhang Z; Yao Y; Ranganathan V; Baglaenko Y; Inman RD
    Ann Rheum Dis; 2016 Dec; 75(12):2124-2132. PubMed ID: 27165176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-resident MAIT cell populations in human oral mucosa exhibit an activated profile and produce IL-17.
    Sobkowiak MJ; Davanian H; Heymann R; Gibbs A; Emgård J; Dias J; Aleman S; Krüger-Weiner C; Moll M; Tjernlund A; Leeansyah E; Sällberg Chen M; Sandberg JK
    Eur J Immunol; 2019 Jan; 49(1):133-143. PubMed ID: 30372518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal-associated invariant T cell alterations during the development of human type 1 diabetes.
    Gazali AM; Schroderus AM; Näntö-Salonen K; Rintamäki R; Pihlajamäki J; Knip M; Veijola R; Toppari J; Ilonen J; Kinnunen T
    Diabetologia; 2020 Nov; 63(11):2396-2409. PubMed ID: 32880687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MR1-Restricted MAIT Cells From The Human Lung Mucosal Surface Have Distinct Phenotypic, Functional, and Transcriptomic Features That Are Preserved in HIV Infection.
    Khuzwayo S; Mthembu M; Meermeier EW; Prakadan SM; Kazer SW; Bassett T; Nyamande K; Khan DF; Maharaj P; Mitha M; Suleman M; Mhlane Z; Ramjit D; Karim F; Shalek AK; Lewinsohn DM; Ndung'u T; Wong EB
    Front Immunol; 2021; 12():631410. PubMed ID: 33897687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.